Cimzia (certolizumab pegol) / UCB, Ferring, Astellas 
Welcome,         Profile    Billing    Logout  

10 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cimzia (certolizumab pegol) / Astellas, UCB
2017-001970-41: Dose reduction and withdrawal of biological therapy in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Protocol for a 18 months multi-centre trial

Ongoing
4
180
Europe
Abatacept, Adalimumab, Certolizumab pegol, Etanercept, Golimumab, Infliximab, Tocilizumab, L04AA24, L04AB04, L04AB05, L04AB01, L04AB06, L04AB02, L04AC07, Concentrate for solution for injection, Concentrate and solvent for solution for infusion, Concentrate and solvent for solution for injection, Concentrate and solvent for suspension for injection, Orencia, Humira, Cimzia, Enbrel, Benepali, Simponi, Remsima, Remicade, RoActemra, Inflectra, Imraldi, Amgevita
MD, PhD Salome Kristensen, The Danish Regions (Regionernes Medicinpulje), The Department of Rheumatology at Aalborg University Hospital, Health Science Research Fund of the Region of Northern Jutland
Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis (arthritis of the spine), Diseases [C] - Musculoskeletal Diseases [C05]
 
 
COVER, NCT05080218: COVID-19 VaccinE Response in Rheumatology Patients

Recruiting
4
1000
US
Upadacitinib, Rinvoq, Abatacept, Orencia SQ, Secukinumab, Cosentyx, Tofacitinib, Xeljanz, TNF Inhibitor, Etanercept, Certolizumab, Golimumab SQ, Adalimumab, Canakinumab Injection, Ilaris, Baricitinib, Olumiant, Ixekizumab, Taltz
Jeffrey Curtis, University of Alabama at Birmingham, University of Nebraska, University of Pennsylvania, AbbVie, Bristol-Myers Squibb, Novartis, Eli Lilly and Company, Pfizer, Illumination Health
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
02/24
09/24
NCT01550003: Pediatric Arthritis Study of Certolizumab Pegol

Checkmark For juvenile idiopathic arthritis
Dec 2016 - Dec 2016: For juvenile idiopathic arthritis
Completed
3
193
Canada, US, RoW
Certolizumab Pegol (CZP), Cimzia
UCB BIOSCIENCES GmbH, PRA Health Sciences
Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
04/24
04/24
CIMcare, NCT04123795: A Study to Evaluate the Efficacy, Safety, and Drug Concentration of Certolizumab Pegol (CZP) in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Recruiting
3
150
Canada, US
Certolizumab pegol, Placebo
UCB Biopharma SRL
Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis
09/29
08/34
DAISY, NCT06028438: A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

Active, not recruiting
2
104
Europe, US, RoW
Placebo, Nipocalimab, JNJ-80202135, M281, Certolizumab, Cimzia
Janssen Research & Development, LLC
Arthritis, Rheumatoid
09/24
11/24
CHERISH, NCT04163016: A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

Completed
1b
22
Europe, US
Pharmacokinetics of certolizumab pegol, PK
UCB Biopharma SRL
Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease, Axial Spondyloarthritis, Plaque Psoriasis
05/23
05/23
NCT03559686: Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)

Available
N/A
NA
Certolizumab Pegol, Cimzia
UCB Biopharma SRL
Rheumatoid Arthritis
 
 
NCT03559660: CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)

Available
N/A
NA
Certolizumab Pegol, Cimzia
UCB Biopharma SRL
Crohn's Disease
 
 
NCT01797224: OTIS Autoimmune Diseases in Pregnancy Project

Recruiting
N/A
925
US
University of California, San Diego, The Organization of Teratology Information Specialists, UCB Pharma
Crohn's Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Psoriasis
09/23
10/26
COMMIT, NCT05702879: Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success

Recruiting
N/A
240
Europe
Ozanimod, TNF Inhibitor, infliximab, adalimumab, etanercept, golimumab, and certolizumab., Steroids, Prednisolon, Vedolizumab, Ustekinumab
Insel Gruppe AG, University Hospital Bern, Bristol-Myers Squibb
Ulcerative Colitis
01/25
01/25

Download Options